Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.125
+0.005 (0.45%)
At close: Jul 28, 2026
BIT:ERFO Revenue
In the year 2025, Laboratorio Farmaceutico Erfo had annual revenue of 9.96M EUR with 57.11% growth. Laboratorio Farmaceutico Erfo had revenue of 4.75M in the half year ending December 31, 2025, with 144.20% growth.
Revenue
9.96M
Revenue Growth
+57.11%
P/S Ratio
0.98
Revenue / Employee
194.63K
Employees
50
Market Cap
9.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.96M | 3.62M | 57.11% |
| Dec 31, 2024 | 6.34M | 919.06K | 16.96% |
| Dec 31, 2023 | 5.42M | 402.40K | 8.02% |
| Dec 31, 2022 | 5.02M | -87.15K | -1.71% |
| Dec 31, 2021 | 5.10M | 904.70K | 21.54% |
| Dec 31, 2020 | 4.20M | -481.17K | -10.28% |
| Dec 31, 2019 | 4.68M | 574.43K | 13.99% |
| Dec 31, 2018 | 4.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Davide Campari-Milano | 3.05B |
| B.F. S.p.A. | 1.73B |
| Intercos | 1.05B |
| Italmobiliare | 778.71M |
| Centrale del Latte d'Italia | 350.57M |
| Enervit | 104.22M |
| Longino & Cardenal | 35.93M |
| Compagnia dei Caraibi | 35.91M |